BioHealth News Archive
BHI Recruiting a Senior Analyst, Immediate Opening.
OVERVIEW BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and…
Read More
Biohealth Startup to Establish $5M HQ in Loudoun – Loudoun Now
Athari Biosciences has selected Loudoun County for its new corporate headquarters. The project includes a wet lab, a tech lab, research and development and…
Read More
Francis Collins
About a decade before becoming NIH Director—a position from which he will step down at year’s end—Francis S. Collins, M.D., Ph.D., was at the…
Read More
CoSolve challenges
CoSolve is a biannual, global Open Innovation programme seeking collaborators with innovative solutions to real research challenges. These challenges lie within our R&D research…
Read More
Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans – Washington Business Journal
The company said Thursday it’s implementing “a two-pronged variant strategy” for the variant. {iframe}https://www.bizjournals.com/washington/news/2021/12/02/novavax-covid-vaccine-omicron-variant-expansion.html{/iframe}
Read More
Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social – The MoCo Show
Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social We recently learned of plans…
Read More
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022 | BioSpace
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a…
Read More
PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease
In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights on the P-I/IIa study…
Read More
Baltimore Startup Rasio Therapeutics Raises $1.5M for Software to Develop Drugs
A Baltimore startup that uses computer software to develop cancer drugs has raised $1.5 million in new funding, according to a recent filing. …
Read More
AB Agri has Partnered with Maryland’s Intralytix, Inc. to Explore the Use of Bacteriophages
Peterborough, 30 November 2021 Gut health could be boosted without reliance on antibiotics and other medicines Bacteriophages are natural and abundant Exploration aligns with…
Read More
Maryland’s Novavax working on its version of COVID-19 vaccine to target omicron variant
GAITHERSBURG, Md. (7News) — The Omicron variant is quickly becoming a household name but the hope is that it won’t enter households here in the D.C. area.…
Read More
Healthtech companies reap benefits of robust year in venture capital funding | Healthcare Finance News
Venture capital investment in global healthtech companies is projected to reach $42 billion by the end of the year, according to Silicon Valley Bank's…
Read More
Bank of antibodies against nasty viruses that’s proposed for Maryland aims to prevent next pandemic.
As the world continues to grapple with the coronavirus pandemic that has claimed more than 5 million lives, a group of researchers is working…
Read More
BioHealth Capital Region Spotlight: Creative Bio-Peptides Awarded $5.78 Million from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications
Creative Bio-Peptides, Inc., an emerging drug development company focused on the development of leading-edge multi-chemokine antagonist therapeutic peptides for neuroinflammatory/neurodegenerative conditions, has been awarded…
Read More
Alexandria Venture Investments, One of the Year’s Top Five Most Active U.S. Investors in Agrifoodtech, Accelerates Its Mission-Critical Investment Activity in a Sector Experiencing Tremendous Upsurge in Venture Funding
PASADENA, Calif., Nov. 29, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an…
Read More